High serum FGF23 concentrations are associated with endothelial dysfunction in patients with CKD (81), and FGF23 has been shown to cause the release of nitric oxide (NO) and the formation of reactive oxygen species (ROS) in human coronary artery endothelial cells (82). This evidence concerns the gene FGF23 and endothelial dysfunction.